Laurion Capital Management LP Agios Pharmaceuticals, Inc. Transaction History
Laurion Capital Management LP
- $8.4 Billion
- Q2 2024
A detailed history of Laurion Capital Management LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 248,395 shares of AGIO stock, worth $11.5 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
248,395
Previous 364,762
31.9%
Holding current value
$11.5 Million
Previous $10.7 Million
0.42%
% of portfolio
0.13%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding AGIO
# of Institutions
226Shares Held
56.2MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$262 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$255 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$225 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$180 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$129 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.54B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...